These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31438515)

  • 1. Different Dynamics in 6aJL2 Proteins Associated with AL Amyloidosis, a Conformational Disease.
    Maya-Martinez R; French-Pacheco L; Valdés-García G; Pastor N; Amero C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis.
    Pelaez-Aguilar AE; Rivillas-Acevedo L; French-Pacheco L; Valdes-Garcia G; Maya-Martinez R; Pastor N; Amero C
    Biochemistry; 2015 Aug; 54(32):4978-86. PubMed ID: 26214579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of 6aJL2 and 6aJL2-R24G amyloidogenics light chain proteins.
    Maya-Martinez R; Gil-Rodriguez P; Amero C
    Biochem Biophys Res Commun; 2015 Jan; 456(2):695-9. PubMed ID: 25522882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cu(II) binding to the λ6aJL2-R24G antibody light chain protein associated with light chain amyloidosis disease: The role of histidines.
    Pelaez-Aguilar AE; Mata-Salgado F; Morales-Ortiz A; Millán-Pacheco C; Olvera-Carranza C; Salgado-Delgado J; Pastor N; Rivillas-Acevedo L
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132393. PubMed ID: 38761898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-Specific Interactions with Copper Promote Amyloid Fibril Formation for λ6aJL2-R24G.
    Pelaez-Aguilar AE; Valdés-García G; French-Pacheco L; Pastor N; Amero C; Rivillas-Acevedo L
    ACS Omega; 2020 Apr; 5(13):7085-7095. PubMed ID: 32280849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation?
    Rudiño-Piñera E; Peláez-Aguilar ÁE; Amero C; Díaz-Vilchis A
    Biochem Biophys Rep; 2019 Dec; 20():100682. PubMed ID: 31517067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Substantial Structural Conversion of the Native Monomer Leads to in-Register Parallel Amyloid Fibril Formation in Light-Chain Amyloidosis.
    Lecoq L; Wiegand T; Rodriguez-Alvarez FJ; Cadalbert R; Herrera GA; Del Pozo-Yauner L; Meier BH; Böckmann A
    Chembiochem; 2019 Apr; 20(8):1027-1031. PubMed ID: 30565364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.
    Blancas-Mejía LM; Tischer A; Thompson JR; Tai J; Wang L; Auton M; Ramirez-Alvarado M
    J Mol Biol; 2014 Jan; 426(2):347-61. PubMed ID: 24157440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of immunoglobulin light chains associated with amyloidosis.
    Omtvedt LA; Bailey D; Renouf DV; Davies MJ; Paramonov NA; Haavik S; Husby G; Sletten K; Hounsell EF
    Amyloid; 2000 Dec; 7(4):227-44. PubMed ID: 11132092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfolding and Aggregation Pathways of Variable Domains from Immunoglobulin Light Chains.
    Meunier-Carmenate Y; Valdés-García G; Maya-Martinez R; French-Pacheco L; Fernández-Silva A; González-Onofre Y; Millan-Pacheco C; Pastor N; Amero C
    Biochemistry; 2023 Mar; 62(5):1000-1011. PubMed ID: 36802343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal stability threshold for amyloid formation in light chain amyloidosis.
    Poshusta TL; Katoh N; Gertz MA; Dispenzieri A; Ramirez-Alvarado M
    Int J Mol Sci; 2013 Nov; 14(11):22604-17. PubMed ID: 24248061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic amyloidoses.
    Blancas-Mejía LM; Ramirez-Alvarado M
    Annu Rev Biochem; 2013; 82():745-74. PubMed ID: 23451869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V; Mangione P; Merlini G
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (1)H, (15)N and (13)C resonance assignments for 3rC and 3rCWP: amyloidogenic variants of imunoglobulin λ 3 light-chain.
    Gil-Rodríguez P; Amero C
    Biomol NMR Assign; 2015 Apr; 9(1):139-42. PubMed ID: 24816896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: A combined NMR and in silico study.
    Mukherjee S; Pondaven SP; Hand K; Madine J; Jaroniec CP
    Sci Rep; 2017 Sep; 7(1):10339. PubMed ID: 28871194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
    Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M
    Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.
    DiCostanzo AC; Thompson JR; Peterson FC; Volkman BF; Ramirez-Alvarado M
    J Biol Chem; 2012 Aug; 287(33):27997-8006. PubMed ID: 22740699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.
    Brumshtein B; Esswein SR; Sawaya MR; Rosenberg G; Ly AT; Landau M; Eisenberg DS
    J Biol Chem; 2018 Dec; 293(51):19659-19671. PubMed ID: 30355736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.